Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: May 13, 2026
Date Accepted: Oct 28, 2026

The final, peer-reviewed published version of this preprint can be found here:

Use of Synchronous, Interruptive Electronic Health Record–Embedded Medication Alerts to Improve Evidence-Based Medication Prescribing: Randomized Comparative Effectiveness Trial of Two Prescriber Alerts

Barnes G, Choi SY, Errickson J, Seagull FJ, Fabbri M, Saraswat A, Dorsch MP, Lanham MS, Smith SN

Use of Synchronous, Interruptive Electronic Health Record–Embedded Medication Alerts to Improve Evidence-Based Medication Prescribing: Randomized Comparative Effectiveness Trial of Two Prescriber Alerts

J Med Internet Res 2026;28:e101057

DOI: 10.2196/101057

Use of Synchronous, Interruptive Electronic Health Record-Embedded Medication Alerts to Improve Evidence-Based Medication Prescribing: Comparative Effectiveness Trial of Two Prescriber Alerts

  • Geoffrey Barnes; 
  • Seo Youn Choi; 
  • Joshua Errickson; 
  • F Jacob Seagull; 
  • Morris Fabbri; 
  • Anish Saraswat; 
  • Michael P Dorsch; 
  • Michael SM Lanham; 
  • Shawna N Smith

ABSTRACT

Background:

Antithrombotic stewardship is critical for reducing preventable harm from inappropriate anticoagulant prescribing. Electronic health record (EHR)–embedded clinical decision support (CDS) alerts can prevent prescribing errors at the point of care, but their real-world effectiveness is variable and often limited by alert fatigue and poor workflow integration. Whether augmenting interruptive medication alerts with just‑in‑time access to clinical pharmacists improves prescriber response remains unclear.

Objective:

This study aimed to (1) compare the effectiveness of synchronous, interruptive direct oral anticoagulant (DOAC) prescribing alerts with and without an embedded clinical pharmacist referral option for correcting inappropriate new prescriptions within 7 days, and (2) evaluate the system‑level impact of implementing synchronous DOAC alerts on inappropriate prescribing over time.

Methods:

We conducted a prescriber‑level randomized comparative effectiveness trial within a large US academic health system. Prescribers who placed an inappropriate ambulatory apixaban or rivaroxaban order were randomized to receive an interruptive EHR alert either with or without an embedded clinical pharmacist referral link. The primary outcome was any change to the prescription within 7 days. In parallel, a system‑level interrupted time series analysis examined weekly proportions of inappropriate DOAC prescriptions (secondary outcomes) from 24 months before through 29 months after alert implementation. Exploratory outcomes included adverse events within 30 days and alert implementation metrics.

Results:

Among 2,082 prescribers writing DOAC prescriptions during the study period, 300 (14.4%) triggered at least one inappropriate prescription and were randomized; after prespecified exclusions, 758 alerts across 286 prescribers were analyzed. Overall, 28.9% (219/758) of alerts led to a prescription change within 7 days. The proportion of alerts leading to a prescription change did not differ between alerts with and without pharmacist referral (difference 1 percentage point [95% CI, −7% to 9%]). The system‑wide proportion of inappropriate DOAC prescriptions exhibited a significant downward pre‑implementation trend (−0.04 percentage points/week [95% CI, −0.06 to −0.02]), followed by an immediate 3.5‑percentage‑point absolute reduction at alert launch (to 9.7%), with no subsequent slope change. Adverse events within 30 days were uncommon and similar across arms.

Conclusions:

Adding an embedded pharmacist referral option to an interruptive DOAC prescribing alert did not increase short‑term prescription changes. However, the implementation of synchronous, user-centered alerts was associated with a substantial and sustained system-level reduction in inappropriate DOAC prescribing. These findings support a complementary digital stewardship model in which high‑value, point‑of‑order alerts prevent routine prescribing errors, while clinical pharmacists focus on complex and longitudinal medication management. Clinical Trial: ClinicalTrials.gov NCT05351749 https://clinicaltrials.gov/study/NCT05351749


 Citation

Please cite as:

Barnes G, Choi SY, Errickson J, Seagull FJ, Fabbri M, Saraswat A, Dorsch MP, Lanham MS, Smith SN

Use of Synchronous, Interruptive Electronic Health Record–Embedded Medication Alerts to Improve Evidence-Based Medication Prescribing: Randomized Comparative Effectiveness Trial of Two Prescriber Alerts

J Med Internet Res 2026;28:e101057

DOI: 10.2196/101057

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.